Logo image of HRPK.DE

7C SOLARPARKEN AG (HRPK.DE) Stock Fundamental Analysis

FRA:HRPK - Deutsche Boerse Ag - DE000A11QW68 - Common Stock - Currency: EUR

1.796  +0.05 (+2.63%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HRPK. HRPK was compared to 22 industry peers in the Independent Power and Renewable Electricity Producers industry. HRPK has an average financial health and profitability rating. HRPK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HRPK had positive earnings in the past year.
In the past year HRPK had a positive cash flow from operations.
Each year in the past 5 years HRPK has been profitable.
In the past 5 years HRPK always reported a positive cash flow from operatings.
HRPK.DE Yearly Net Income VS EBIT VS OCF VS FCFHRPK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

HRPK has a Return On Assets (0.08%) which is comparable to the rest of the industry.
The Return On Equity of HRPK (0.21%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 1.56%, HRPK perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HRPK is in line with the industry average of 5.28%.
Industry RankSector Rank
ROA 0.08%
ROE 0.21%
ROIC 1.56%
ROA(3y)2.05%
ROA(5y)1.85%
ROE(3y)5.16%
ROE(5y)4.85%
ROIC(3y)3.92%
ROIC(5y)3.5%
HRPK.DE Yearly ROA, ROE, ROICHRPK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

HRPK has a Profit Margin of 0.71%. This is comparable to the rest of the industry: HRPK outperforms 50.00% of its industry peers.
HRPK's Profit Margin has declined in the last couple of years.
HRPK has a Operating Margin (15.58%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of HRPK has declined.
Industry RankSector Rank
OM 15.58%
PM (TTM) 0.71%
GM N/A
OM growth 3Y-20.96%
OM growth 5Y-13.74%
PM growth 3Y-65.62%
PM growth 5Y-47.74%
GM growth 3YN/A
GM growth 5YN/A
HRPK.DE Yearly Profit, Operating, Gross MarginsHRPK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HRPK is still creating some value.
HRPK has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for HRPK has been increased compared to 5 years ago.
Compared to 1 year ago, HRPK has a worse debt to assets ratio.
HRPK.DE Yearly Shares OutstandingHRPK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
HRPK.DE Yearly Total Debt VS Total AssetsHRPK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

HRPK has an Altman-Z score of 0.61. This is a bad value and indicates that HRPK is not financially healthy and even has some risk of bankruptcy.
HRPK has a Altman-Z score of 0.61. This is comparable to the rest of the industry: HRPK outperforms 45.45% of its industry peers.
HRPK has a debt to FCF ratio of 5.63. This is a neutral value as HRPK would need 5.63 years to pay back of all of its debts.
HRPK has a Debt to FCF ratio of 5.63. This is amongst the best in the industry. HRPK outperforms 90.91% of its industry peers.
HRPK has a Debt/Equity ratio of 0.85. This is a neutral value indicating HRPK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.85, HRPK is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 5.63
Altman-Z 0.61
ROIC/WACC0.42
WACC3.7%
HRPK.DE Yearly LT Debt VS Equity VS FCFHRPK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

HRPK has a Current Ratio of 1.48. This is a normal value and indicates that HRPK is financially healthy and should not expect problems in meeting its short term obligations.
HRPK has a Current ratio (1.48) which is in line with its industry peers.
HRPK has a Quick Ratio of 1.46. This is a normal value and indicates that HRPK is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.46, HRPK perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.46
HRPK.DE Yearly Current Assets VS Current LiabilitesHRPK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

HRPK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.52%.
The earnings per share for HRPK have been decreasing by -47.56% on average. This is quite bad
The Revenue has decreased by -9.37% in the past year.
HRPK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)-93.52%
EPS 3Y-65.73%
EPS 5Y-47.56%
EPS Q2Q%-108.55%
Revenue 1Y (TTM)-9.37%
Revenue growth 3Y4.02%
Revenue growth 5Y7.97%
Sales Q2Q%-4.3%

3.2 Future

The Earnings Per Share is expected to grow by 1.66% on average over the next years.
The Revenue is expected to decrease by -2.94% on average over the next years.
EPS Next Y52.63%
EPS Next 2Y21.4%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue Next Year5.14%
Revenue Next 2Y3.66%
Revenue Next 3Y2.42%
Revenue Next 5Y-2.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HRPK.DE Yearly Revenue VS EstimatesHRPK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M
HRPK.DE Yearly EPS VS EstimatesHRPK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.05 0.1 0.15 0.2 0.25

4

4. Valuation

4.1 Price/Earnings Ratio

HRPK is valuated quite expensively with a Price/Earnings ratio of 179.60.
HRPK's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, HRPK is valued quite expensively.
A Price/Forward Earnings ratio of 12.14 indicates a correct valuation of HRPK.
HRPK's Price/Forward Earnings ratio is rather cheap when compared to the industry. HRPK is cheaper than 81.82% of the companies in the same industry.
HRPK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 179.6
Fwd PE 12.14
HRPK.DE Price Earnings VS Forward Price EarningsHRPK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

HRPK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HRPK is cheaper than 72.73% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HRPK indicates a rather cheap valuation: HRPK is cheaper than 95.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 6.43
HRPK.DE Per share dataHRPK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HRPK does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.41
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3Y1.66%

0

5. Dividend

5.1 Amount

HRPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

7C SOLARPARKEN AG

FRA:HRPK (7/11/2025, 7:00:00 PM)

1.796

+0.05 (+2.63%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)05-28 2025-05-28
Earnings (Next)09-17 2025-09-17
Inst Owners9.5%
Inst Owner ChangeN/A
Ins Owners7.45%
Ins Owner ChangeN/A
Market Cap146.14M
Analysts42.22
Price Target3.67 (104.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-4.82%
DP1427.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 179.6
Fwd PE 12.14
P/S 2.31
P/FCF 3.33
P/OCF 2.97
P/B 0.67
P/tB 0.68
EV/EBITDA 6.43
EPS(TTM)0.01
EY0.56%
EPS(NY)0.15
Fwd EY8.23%
FCF(TTM)0.54
FCFY30.01%
OCF(TTM)0.61
OCFY33.7%
SpS0.78
BVpS2.7
TBVpS2.65
PEG (NY)3.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.21%
ROCE 2.07%
ROIC 1.56%
ROICexc 1.86%
ROICexgc 1.88%
OM 15.58%
PM (TTM) 0.71%
GM N/A
FCFM 69.32%
ROA(3y)2.05%
ROA(5y)1.85%
ROE(3y)5.16%
ROE(5y)4.85%
ROIC(3y)3.92%
ROIC(5y)3.5%
ROICexc(3y)4.29%
ROICexc(5y)3.86%
ROICexgc(3y)4.32%
ROICexgc(5y)3.89%
ROCE(3y)5.2%
ROCE(5y)4.65%
ROICexcg growth 3Y-21.25%
ROICexcg growth 5Y-13.6%
ROICexc growth 3Y-21.3%
ROICexc growth 5Y-13.46%
OM growth 3Y-20.96%
OM growth 5Y-13.74%
PM growth 3Y-65.62%
PM growth 5Y-47.74%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 5.63
Debt/EBITDA 4.02
Cap/Depr 14.69%
Cap/Sales 8.52%
Interest Coverage 1.81
Cash Conversion 105.86%
Profit Quality 9725.06%
Current Ratio 1.48
Quick Ratio 1.46
Altman-Z 0.61
F-Score5
WACC3.7%
ROIC/WACC0.42
Cap/Depr(3y)21.59%
Cap/Depr(5y)26.7%
Cap/Sales(3y)10.56%
Cap/Sales(5y)13.97%
Profit Quality(3y)3432.97%
Profit Quality(5y)2234.89%
High Growth Momentum
Growth
EPS 1Y (TTM)-93.52%
EPS 3Y-65.73%
EPS 5Y-47.56%
EPS Q2Q%-108.55%
EPS Next Y52.63%
EPS Next 2Y21.4%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.37%
Revenue growth 3Y4.02%
Revenue growth 5Y7.97%
Sales Q2Q%-4.3%
Revenue Next Year5.14%
Revenue Next 2Y3.66%
Revenue Next 3Y2.42%
Revenue Next 5Y-2.94%
EBIT growth 1Y-61.56%
EBIT growth 3Y-17.78%
EBIT growth 5Y-6.86%
EBIT Next Year217.14%
EBIT Next 3Y54.28%
EBIT Next 5Y36.96%
FCF growth 1Y28.37%
FCF growth 3Y23.7%
FCF growth 5Y19.91%
OCF growth 1Y9.4%
OCF growth 3Y7%
OCF growth 5Y12.06%